SYNAPTIC PLASTICITY IN THE RAT STRIATUM FOLLOWING CHRONIC HALOPERIDOL TREATMENT

被引:69
|
作者
KERNS, JM
SIERENS, DK
KAO, LC
KLAWANS, HL
CARVEY, PM
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT NEUROL SCI, 2242 W HARRISON ST AF0048, CHICAGO, IL 60612 USA
[2] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT ANAT, CHICAGO, IL 60612 USA
[3] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT PHARMACOL, CHICAGO, IL 60612 USA
关键词
DOPAMINE; HALOPERIDOL; SYNAPTIC PLASTICITY; TROPHIC FACTORS; STRIATUM; PERFORATED SYNAPSES;
D O I
10.1097/00002826-199212000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors.
引用
收藏
页码:488 / 500
页数:13
相关论文
共 50 条
  • [1] EFFECT OF CHRONIC HALOPERIDOL TREATMENT ON STIMULATED SYNAPTIC OVERFLOW OF DOPAMINE IN THE RAT STRIATUM
    WIEDEMANN, DJ
    GARRIS, PA
    NEAR, JA
    WIGHTMAN, RM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 261 (02): : 574 - 579
  • [2] THE EFFECTS OF HALOPERIDOL ON SYNAPTIC PATTERNS IN THE RAT STRIATUM
    BENES, FM
    PASKEVICH, PA
    DAVIDSON, J
    DOMESICK, VB
    BRAIN RESEARCH, 1985, 329 (1-2) : 265 - 273
  • [3] ESTIMATION OF HALOPERIDOL CONCENTRATIONS IN RAT STRIATUM AFTER CHRONIC TREATMENT
    BELLOWS, EP
    BARNES, DE
    CSERNANSKY, JG
    BRAIN RESEARCH BULLETIN, 1991, 26 (05) : 715 - 719
  • [4] The effect of chronic haloperidol treatment on dendritic spines in the rat striatum
    Kelley, JJ
    Gao, XM
    Tamminga, CA
    Roberts, RC
    EXPERIMENTAL NEUROLOGY, 1997, 146 (02) : 471 - 478
  • [5] CHRONIC TREATMENT WITH HALOPERIDOL ACCELERATES BIOSYNTHESIS OF ENKEPHALINS IN RAT STRIATUM
    HONG, JS
    YANG, HYT
    GILLIN, JC
    DIGIULIO, AM
    FRATTA, W
    COSTA, E
    BRAIN RESEARCH, 1979, 160 (01) : 192 - 195
  • [6] The effect of chronic haloperidol treatment on dendritic spines in the rat striatum
    Kelley, JJ
    Gao, XM
    Tamminga, CA
    Roberts, RC
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 28 - 28
  • [7] Chronic haloperidol treatment impairs glutamate transport in the rat striatum
    De Souza, IEJ
    McBean, GJ
    Meredith, GE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 382 (02) : 139 - 142
  • [8] Effects of chronic haloperidol treatment on proteomic profiles in the rat striatum
    Dedova, IV
    Schleimer, SB
    Dedov, VN
    Johnston, GA
    Henderson, JM
    Matsumoto, I
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 229 - 229
  • [9] SYNAPTIC PLASTICITY IN RAT MEDIAL PREFRONTAL CORTEX UNDER CHRONIC HALOPERIDOL TREATMENT PRODUCED BEHAVIORAL SENSITIZATION
    KLINZOVA, AJ
    URANOVA, NA
    HASELHORST, U
    SCHENK, H
    JOURNAL FUR HIRNFORSCHUNG, 1990, 31 (02): : 175 - 179
  • [10] Repeated treatment with haloperidol, but not olanzapine, alters synaptic NMDA receptor composition in rat striatum
    Gardoni, Fabrizio
    Frasca, Angelisa
    Zianni, Elisa
    Riva, Marco A.
    Di Luca, Monica
    Fumagalli, Fabio
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (07) : 531 - 534